Costamare (CMRE)
(Delayed Data from NYSE)
$13.73 USD
+0.12 (0.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $13.64 -0.09 (-0.66%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$13.73 USD
+0.12 (0.88%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $13.64 -0.09 (-0.66%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth F Momentum B VGM
Zacks News
Near-Term Outlook for Shipping Stocks Appears Enthralling
by Maharathi Basu
The recent positive developments between the United States and China bode well for global trade, which in turn is favorable for the shipping industry.
Costamare (CMRE) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Costamare (CMRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Top Ranked Income Stocks to Buy for November 4th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, November 4th.
Top Ranked Income Stocks to Buy for October 31st
by Zacks Equity Research
Here are four stocks with buy rank and s.rong income characteristics for investors to consider today, October 31st
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial
by Zacks Equity Research
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial
Six Scorching Hot Stocks to Buy
by David Bartosiak
These six Zacks Rank #1 (Strong Buy) stocks are breaking out to new highs.
Is Costamare (CMRE) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
5 Solid Relative Price Strength Stocks to Make You Rich
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Top Ranked Income Stocks to Buy for October 29th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 29th
Top Ranked Income Stocks to Buy for October 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 25th.
Top Ranked Momentum Stocks to Buy for October 25th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 25th:
Costamare (CMRE) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Costamare (CMRE) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Costamare (CMRE) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Costamare (CMRE) delivered earnings and revenue surprises of 36.84% and 6.14%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Top Ranked Income Stocks to Buy for October 22nd
by Zacks Equity Research
Here are three stocks with buy rank and strong income characteristics for investors to consider today, October 22nd
Top Ranked Momentum Stocks to Buy for October 22nd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 22nd
Here's Why Costamare (CMRE) is a Great Momentum Stock to Buy
by Zacks Equity Research
Does Costamare (CMRE) have what it takes to be a top stock pick for momentum investors? Let's find out.
All You Need to Know About Costamare (CMRE) Rating Upgrade to Strong Buy
by Zacks Equity Research
Costamare (CMRE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for October 18th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Top Ranked Income Stocks to Buy for October 18th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 18th
Costamare (CMRE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Costamare (CMRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Costamare (CMRE) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Costamare (CMRE) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Frontline (FRO) in Focus: Stock Moves 5.4% Higher
by Zacks Equity Research
Frontline (FRO) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Top Ranked Income Stocks to Buy for September 13th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, September 13th
Should Value Investors Buy Costamare (CMRE) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.